Boston Scientific Corporation (BSX)
USD 88.03
(-2.65%)
USD 88.03
(-2.65%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.59 Billion USD | 128.22% |
| 2022 | 698 Million USD | -32.95% |
| 2021 | 1.04 Billion USD | 843.57% |
| 2020 | -140 Million USD | -102.98% |
| 2019 | 4.7 Billion USD | 181.27% |
| 2018 | 1.67 Billion USD | 1506.73% |
| 2017 | 104 Million USD | -70.03% |
| 2016 | 347 Million USD | 245.19% |
| 2015 | -239 Million USD | -189.51% |
| 2014 | 267 Million USD | 320.66% |
| 2013 | -121 Million USD | 97.03% |
| 2012 | -4.06 Billion USD | -1022.45% |
| 2011 | 441 Million USD | 141.41% |
| 2010 | -1.06 Billion USD | -3.9% |
| 2009 | -1.02 Billion USD | 50.53% |
| 2008 | -2.07 Billion USD | -318.59% |
| 2007 | -495 Million USD | 86.16% |
| 2006 | -3.57 Billion USD | -669.59% |
| 2005 | 628 Million USD | -40.87% |
| 2004 | 1.06 Billion USD | 125.0% |
| 2003 | 472 Million USD | 26.54% |
| 2002 | 373 Million USD | 790.74% |
| 2001 | -54 Million USD | -114.48% |
| 2000 | 373 Million USD | 0.54% |
| 1999 | 371 Million USD | 240.32% |
| 1998 | -264.4 Million USD | -289.81% |
| 1997 | 139.3 Million USD | -16.64% |
| 1996 | 167.1 Million USD | 1988.75% |
| 1995 | 8 Million USD | -89.96% |
| 1994 | 79.7 Million USD | 14.35% |
| 1993 | 69.7 Million USD | 23.14% |
| 1992 | 56.6 Million USD | 35.41% |
| 1991 | 41.8 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 492 Million USD | -2.57% |
| 2024 Q3 | 468 Million USD | 44.44% |
| 2024 Q2 | 324 Million USD | -34.15% |
| 2023 Q2 | 270 Million USD | -14.01% |
| 2023 Q4 | 505 Million USD | 0.2% |
| 2023 Q1 | 314 Million USD | 124.29% |
| 2023 Q3 | 504 Million USD | 86.67% |
| 2023 FY | 1.59 Billion USD | 128.22% |
| 2022 Q4 | 140 Million USD | -19.54% |
| 2022 FY | 698 Million USD | -32.95% |
| 2022 Q3 | 174 Million USD | -29.27% |
| 2022 Q1 | 96 Million USD | 17.07% |
| 2022 Q2 | 246 Million USD | 156.25% |
| 2021 Q2 | 172 Million USD | -47.4% |
| 2021 Q1 | 327 Million USD | 115.13% |
| 2021 Q4 | 82 Million USD | -79.75% |
| 2021 Q3 | 405 Million USD | 135.47% |
| 2021 FY | 1.04 Billion USD | 843.57% |
| 2020 FY | -140 Million USD | -102.98% |
| 2020 Q1 | 11 Million USD | -99.72% |
| 2020 Q2 | -147 Million USD | -1436.36% |
| 2020 Q3 | -155 Million USD | -5.44% |
| 2020 Q4 | 152 Million USD | 198.06% |
| 2019 Q3 | 126 Million USD | -18.18% |
| 2019 FY | 4.7 Billion USD | 181.27% |
| 2019 Q4 | 3.99 Billion USD | 3071.43% |
| 2019 Q2 | 154 Million USD | -63.68% |
| 2019 Q1 | 424 Million USD | 9.84% |
| 2018 FY | 1.67 Billion USD | 1506.73% |
| 2018 Q3 | 432 Million USD | -22.16% |
| 2018 Q2 | 555 Million USD | 86.24% |
| 2018 Q1 | 298 Million USD | 148.46% |
| 2018 Q4 | 386 Million USD | -10.65% |
| 2017 Q2 | 146 Million USD | -49.66% |
| 2017 FY | 104 Million USD | -70.03% |
| 2017 Q3 | 283 Million USD | 93.84% |
| 2017 Q4 | -615 Million USD | -317.31% |
| 2017 Q1 | 290 Million USD | 133.87% |
| 2016 Q2 | -207 Million USD | -202.48% |
| 2016 Q1 | 202 Million USD | 242.25% |
| 2016 FY | 347 Million USD | 245.19% |
| 2016 Q3 | 228 Million USD | 210.14% |
| 2016 Q4 | 124 Million USD | -45.61% |
| 2015 Q1 | -1 Million USD | -101.15% |
| 2015 Q2 | 102 Million USD | 10300.0% |
| 2015 Q3 | -198 Million USD | -294.12% |
| 2015 Q4 | -142 Million USD | 28.28% |
| 2015 FY | -239 Million USD | -189.51% |
| 2014 FY | 267 Million USD | 320.66% |
| 2014 Q4 | 87 Million USD | 102.33% |
| 2014 Q3 | 43 Million USD | 975.0% |
| 2014 Q2 | 4 Million USD | -96.99% |
| 2014 Q1 | 133 Million USD | 23.15% |
| 2013 Q4 | 108 Million USD | 2260.0% |
| 2013 Q1 | -354 Million USD | -680.33% |
| 2013 Q2 | 130 Million USD | 136.72% |
| 2013 FY | -121 Million USD | 97.03% |
| 2013 Q3 | -5 Million USD | -103.85% |
| 2012 Q2 | -3.4 Billion USD | -3112.39% |
| 2012 Q1 | 113 Million USD | 5.61% |
| 2012 FY | -4.06 Billion USD | -1022.45% |
| 2012 Q4 | 61 Million USD | 108.41% |
| 2012 Q3 | -725 Million USD | 78.7% |
| 2011 FY | 441 Million USD | 141.41% |
| 2011 Q1 | 20 Million USD | -91.53% |
| 2011 Q2 | 146 Million USD | 630.0% |
| 2011 Q3 | 142 Million USD | -2.74% |
| 2011 Q4 | 107 Million USD | -24.65% |
| 2010 Q3 | 190 Million USD | 93.88% |
| 2010 Q1 | -1.58 Billion USD | -47.68% |
| 2010 Q2 | 98 Million USD | 106.17% |
| 2010 Q4 | 236 Million USD | 24.21% |
| 2010 FY | -1.06 Billion USD | -3.9% |
| 2009 Q1 | -13 Million USD | 99.46% |
| 2009 Q4 | -1.07 Billion USD | -638.0% |
| 2009 Q3 | 200 Million USD | 26.58% |
| 2009 Q2 | 158 Million USD | 1315.38% |
| 2009 FY | -1.02 Billion USD | 50.53% |
| 2008 Q4 | -2.39 Billion USD | -3761.29% |
| 2008 Q3 | -62 Million USD | -163.27% |
| 2008 Q2 | 98 Million USD | -69.57% |
| 2008 Q1 | 322 Million USD | 170.31% |
| 2008 FY | -2.07 Billion USD | -318.59% |
| 2007 FY | -495 Million USD | 86.16% |
| 2007 Q4 | -458 Million USD | -68.38% |
| 2007 Q3 | -272 Million USD | -336.52% |
| 2007 Q2 | 115 Million USD | -4.17% |
| 2007 Q1 | 120 Million USD | -56.68% |
| 2006 Q4 | 277 Million USD | 264.47% |
| 2006 Q3 | 76 Million USD | 101.78% |
| 2006 Q2 | -4.26 Billion USD | -1383.73% |
| 2006 Q1 | 332 Million USD | -0.6% |
| 2006 FY | -3.57 Billion USD | -669.59% |
| 2005 Q4 | 334 Million USD | 224.16% |
| 2005 Q3 | -269 Million USD | -231.22% |
| 2005 Q2 | 205 Million USD | -42.74% |
| 2005 FY | 628 Million USD | -40.87% |
| 2005 Q1 | 358 Million USD | 20.54% |
| 2004 Q2 | 313 Million USD | 61.34% |
| 2004 Q4 | 297 Million USD | 15.12% |
| 2004 FY | 1.06 Billion USD | 125.0% |
| 2004 Q1 | 194 Million USD | 41.61% |
| 2004 Q3 | 258 Million USD | -17.57% |
| 2003 Q4 | 137 Million USD | 10.48% |
| 2003 Q2 | 114 Million USD | 17.53% |
| 2003 Q1 | 97 Million USD | -7.62% |
| 2003 FY | 472 Million USD | 26.54% |
| 2003 Q3 | 124 Million USD | 8.77% |
| 2002 FY | 373 Million USD | 790.74% |
| 2002 Q4 | 105 Million USD | -34.78% |
| 2002 Q3 | 161 Million USD | 544.0% |
| 2002 Q2 | 25 Million USD | -69.51% |
| 2002 Q1 | 82 Million USD | 26.15% |
| 2001 Q2 | -172 Million USD | -3340.0% |
| 2001 Q4 | 65 Million USD | 12.07% |
| 2001 FY | -54 Million USD | -114.48% |
| 2001 Q1 | -5 Million USD | -108.33% |
| 2001 Q3 | 58 Million USD | 133.72% |
| 2000 Q3 | 85 Million USD | -30.33% |
| 2000 Q1 | 106 Million USD | -0.93% |
| 2000 Q2 | 122 Million USD | 15.09% |
| 2000 FY | 373 Million USD | 0.54% |
| 2000 Q4 | 60 Million USD | -29.41% |
| 1999 Q1 | 100 Million USD | 0.6% |
| 1999 Q4 | 107 Million USD | 94.55% |
| 1999 Q3 | 55 Million USD | -49.54% |
| 1999 Q2 | 109 Million USD | 9.0% |
| 1999 FY | 371 Million USD | 240.32% |
| 1998 FY | -264.4 Million USD | -289.81% |
| 1998 Q1 | 60 Million USD | 2400.0% |
| 1998 Q2 | 67 Million USD | 11.67% |
| 1998 Q3 | -509.4 Million USD | -860.3% |
| 1998 Q4 | 99.4 Million USD | 119.51% |
| 1997 Q4 | 2.4 Million USD | -97.29% |
| 1997 FY | 139.3 Million USD | -16.64% |
| 1997 Q1 | 75.4 Million USD | -1.69% |
| 1997 Q2 | -26.9 Million USD | -135.68% |
| 1997 Q3 | 88.4 Million USD | 428.62% |
| 1996 Q1 | -1 Million USD | 93.87% |
| 1996 Q4 | 76.7 Million USD | 7.72% |
| 1996 Q3 | 71.2 Million USD | 202.98% |
| 1996 Q2 | 23.5 Million USD | 2450.0% |
| 1996 FY | 167.1 Million USD | 1988.75% |
| 1995 Q3 | 47 Million USD | 2.4% |
| 1995 Q4 | -16.3 Million USD | -134.68% |
| 1995 FY | 8 Million USD | -89.96% |
| 1995 Q1 | -68.6 Million USD | -396.97% |
| 1995 Q2 | 45.9 Million USD | 166.91% |
| 1994 Q4 | 23.1 Million USD | 16.67% |
| 1994 Q2 | 18.8 Million USD | 4.44% |
| 1994 Q1 | 18 Million USD | -11.33% |
| 1994 Q3 | 19.8 Million USD | 5.32% |
| 1994 FY | 79.7 Million USD | 14.35% |
| 1993 Q1 | 15.3 Million USD | -1.92% |
| 1993 Q2 | 16.8 Million USD | 9.8% |
| 1993 Q3 | 17.3 Million USD | 2.98% |
| 1993 Q4 | 20.3 Million USD | 17.34% |
| 1993 FY | 69.7 Million USD | 23.14% |
| 1992 FY | 56.6 Million USD | 35.41% |
| 1992 Q4 | 15.6 Million USD | 2.63% |
| 1992 Q3 | 15.2 Million USD | 14.29% |
| 1992 Q2 | 13.3 Million USD | 6.4% |
| 1992 Q1 | 12.5 Million USD | 17.92% |
| 1991 Q1 | 9.5 Million USD | 0.0% |
| 1991 Q4 | 10.6 Million USD | -2.75% |
| 1991 Q3 | 10.9 Million USD | 0.93% |
| 1991 FY | 41.8 Million USD | 0.0% |
| 1991 Q2 | 10.8 Million USD | 13.68% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Abbott Laboratories | 5.72 Billion USD | 72.165% |
| Allurion Technologies Inc. | -82.3 Million USD | 2035.507% |
| Artivion, Inc. | -30.69 Million USD | 5290.616% |
| Avanos Medical, Inc. | -61.8 Million USD | 2677.67% |
| Butterfly Network, Inc. | -133.69 Million USD | 1291.473% |
| Butterfly Network, Inc. | -133.69 Million USD | 1291.473% |
| Bio-Rad Laboratories, Inc. | -637.32 Million USD | 349.951% |
| Perspective Therapeutics, Inc. | -14.67 Million USD | 10958.896% |
| CONMED Corporation | 64.45 Million USD | -2371.338% |
| Edwards Lifesciences Corporation | 1.4 Billion USD | -13.591% |
| Paragon 28, Inc. | -47.84 Million USD | 3429.78% |
| Glaukos Corporation | -134.66 Million USD | 1282.971% |
| Globus Medical, Inc. | 122.87 Million USD | -1196.461% |
| Inspire Medical Systems, Inc. | -21.15 Million USD | 7630.847% |
| Integer Holdings Corporation | 90.65 Million USD | -1657.308% |
| Medtronic plc | 3.67 Billion USD | 56.665% |
| Nevro Corp. | -92.21 Million USD | 1827.522% |
| Owlet, Inc. | -32.9 Million USD | 4941.798% |
| Penumbra, Inc. | 90.95 Million USD | -1651.435% |
| Vicarious Surgical Inc. | -71.07 Million USD | 2341.421% |
| Smith & Nephew plc | 263 Million USD | -505.703% |
| Sonendo, Inc. | -60.91 Million USD | 2714.948% |
| STERIS plc | 378.23 Million USD | -321.162% |
| Stryker Corporation | 3.16 Billion USD | 49.668% |
| Vapotherm, Inc. | -58.19 Million USD | 2837.443% |
| Zimmer Biomet Holdings, Inc. | 1.02 Billion USD | -55.566% |